Dermatophytic Onychomycosis Treatment
A Global Strategic Business Report
MCP11505
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (171)
12
CXO31
VICE PRESIDENT63
DIRECTOR24
MANAGER41
MARKETING
REQUEST FULL-STACK INDEX
Includes 350+ pages validated sources
QUESTIONNAIRE
EXECUTIVES
DATA ROOM
HIGHLIGHTS & REPORT INDEX
Global Dermatophytic Onychomycosis Treatment Market to Reach US$10.6 Billion by 2030
The global market for Dermatophytic Onychomycosis Treatment estimated at US$7.9 Billion in the year 2024, is expected to reach US$10.6 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Topical Therapy, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$7.1 Billion by the end of the analysis period. Growth in the Systemic Therapy segment is estimated at 3.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 4.8% CAGR
The Dermatophytic Onychomycosis Treatment market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.
Global Dermatophytic Onychomycosis Treatment Market - Key Trends and Drivers Summarized
What Is Dermatophytic Onychomycosis and Why Is It a Concern?
Dermatophytic onychomycosis, commonly referred to as toenail fungus, involves a fungal infection that affects the nails, primarily the toenails. It is caused by dermatophytes, a type of fungus that thrives in warm, moist environments, making toenails a prime target due to their frequent enclosure in shoes. This condition is characterized by thickening, discoloration, and splitting of the nail, and can be quite painful, often leading to significant discomfort and embarrassment. The prevalence of onychomycosis is particularly high among the elderly, diabetic, and those with compromised immune systems, who are at greater risk due to poorer circulation and reduced nail growth. Treatment is crucial not only for cosmetic reasons but also to prevent the spread of the infection to other nails or, more seriously, to other individuals. Effective management of the condition requires a combination of pharmacological treatments and, in some cases, surgical intervention.
How Are Current Treatments Evolving in the Fight Against Onychomycosis?
The treatment landscape for dermatophytic onychomycosis has evolved significantly over the past decade, with a shift towards more effective and less invasive options. Traditionally, the approach has included oral antifungal medications, which are effective but can have serious side effects, such as liver damage or skin rashes, necessitating regular monitoring with blood tests. Topical treatments are safer but generally less effective, especially for more severe infections. Recent advancements have led to the development of more efficient topical solutions, improved oral medications with fewer side effects, and novel treatment modalities like laser and photodynamic therapy. These newer methods target the fungus more directly, potentially reducing treatment duration and improving efficacy with minimal side effects. Additionally, there is a growing interest in the use of natural and alternative remedies, which appeal to patients seeking less harsh treatment options.
What Role Does Technology Play in Enhancing Treatment Outcomes?
Innovations in technology are playing a pivotal role in improving the diagnosis and treatment of dermatophytic onychomycosis. Advanced imaging techniques, such as optical coherence tomography, allow for more accurate visualization of the infection extent, facilitating more targeted treatments. Additionally, the development of laser therapy has introduced a new dimension to onychomycosis management, offering a quick, safe, and repeatable treatment option without the side effects associated with systemic therapies. These lasers work by penetrating the nail and destroying the fungi with heat without damaging the surrounding nail or skin. Moreover, ongoing research into the delivery mechanisms of topical treatments is enhancing their effectiveness; for example, new forms of medication that can better penetrate the nail`s hard exterior are currently being developed. This technological progress not only improves patient outcomes but also enhances the overall efficiency of treatment protocols.
What Drives the Growing Market for Dermatophytic Onychomycosis Treatment?
The growth in the dermatophytic onychomycosis treatment market is driven by several factors, including an aging global population, which is more susceptible to fungal infections due to decreased immunity and poor blood circulation. Increased awareness and better diagnostic techniques are also contributing to higher treatment rates. Furthermore, lifestyle changes that increase exposure to communal areas such as gyms, pools, and spas are leading to a higher incidence of fungal infections. The development of newer, more effective, and safer treatments, along with a rising preference for aesthetic appearance, is fueling demand for advanced onychomycosis treatments. As healthcare providers continue to seek more efficient and patient-friendly treatment options, the market is expected to expand, with continued innovations and improvements in both pharmacological and technological domains driving growth further.
SCOPE OF STUDY
The report analyzes the Dermatophytic Onychomycosis Treatment market by the following Segments, and Geographic Regions/Countries:
Segments:
Segment (Topical Therapy, Systemic Therapy, Device-Based Therapy); End-Use (Dermatology Clinics, Hospitals, Retail Pharmacies, Other End-Uses).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..
SELECT PLAYERS
Allergan PLC; Galderma SA; GlaxoSmithKline PLC; Johnson & Johnson; Moberg Pharma AB; NovaBiotics Ltd; Novartis AG; Pfizer, Inc.; Sanofi SA; Valeant Pharmaceuticals International, Inc.
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| Dermatophytic Onychomycosis Treatment – Global Key Competitors Percentage Market Share in 2024 (E) |
| Global Economic Update |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 44 Players Worldwide in 2024 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Rising Global Incidence of Diabetes Bolsters Demand for Onychomycosis Treatment |
| Advances in Antifungal Therapies Propel Market Growth |
| Increased Awareness of Foot Health Drives Adoption of Treatments |
| Growing Elderly Population Sustains Demand for Effective Onychomycosis Solutions |
| Expansion of Over-the-Counter Antifungal Products Generates Greater Consumer Access |
| The Role of Podiatrists and Dermatologists in Driving Treatment Adoption |
| Telemedicine and Online Consultations Expand Patient Reach |
| Growing Demand for Natural and Alternative Treatment Options |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Dermatophytic Onychomycosis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Systemic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Systemic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Systemic Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Topical Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Topical Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Topical Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Device-based Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Device-based Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Device-based Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Dermatology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Dermatophytic Onychomycosis Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2015, 2025 & 2030 |
| JAPAN |
| Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2015, 2025 & 2030 |
| CHINA |
| Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2015, 2025 & 2030 |
| EUROPE |
| Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Dermatophytic Onychomycosis Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2015, 2025 & 2030 |
| FRANCE |
| Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2015, 2025 & 2030 |
| GERMANY |
| Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2015, 2025 & 2030 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2015, 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]